Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 1-A Offering statement
- PART II AND III Part II and III
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
- ADD EXHB Add Exhb
Associated filings
- 17 Oct 24 253G2 Offering circular supplement
- 9 Oct 24 QUALIF Notice of qualification
- 4 Oct 24 1-A/A Offering $10.00 mm in Equity
- 26 Sep 24 1-A/A Offering $10.00 mm in Equity
-
30 Jul 24 1-A Offering $10.00 mm in Equity
BirchBioMed similar filings
Filing view
External links
Exhibit 11.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in the Offering Statement on Form 1-A of our report dated April 8, 2024 (which report expresses an unqualified opinion and includes an explanatory paragraph related to BirchBioMed Inc.’s ability to continue as a going concern) with respect to our audit of the financial statements of BirchBioMed Inc. as of September 30, 2023 and 2022, and for the years then ended. We also hereby consent to the reference to our firm under the heading “Experts” in the Offering Circular, which is part of this Offering Statement.
/s/ Bonadio & Co., LLP
Rochester, New York
July 30, 2024